Key result
In a canine model of acute pulmonary hypertension, hydralazine improved RV performance and gas exchange, whereas nitroglycerin and prostaglandin E1 exerted no beneficial cardiopulmonary effects.
Why the study?
Do vasodilators (nitroglycerin, prostaglandin E1, hydralazine) improve RV function and gas exchange in a canine model of acute pulmonary hypertension?
Do vasodilators (nitroglycerin, prostaglandin E1, hydralazine) improve RV function and gas exchange in a canine model of acute pulmonary hypertension?
In a canine model of acute pulmonary hypertension, hydralazine improved cardiopulmonary hemodynamics and gas exchange, whereas nitroglycerin and prostaglandin E1 were detrimental.
Answers are grounded in this paper and cite their sources.
May inform vasodilator selection in experimental acute PH; leaves open human translation and optimal RV support.
This study was performed to determine 1) the effects of acute pulmonary embolization (induced by injection of autologous muscle) on right ventricular (RV) performance, coronary hemodynamics, and gas exchange; and 2) the efficacy of subsequent administration of nitroglycerin, prostaglandin E1, and hydralazine with regard to improvement in RV function and gas exchange in eight open-chest dogs. After embolization, pulmonary artery (PA) pressure and vascular resistance (PVR) increased three- to fivefold without changes in RV end-diastolic dimensions (ultrasonic dimension technique) or pressure. However, systolic dimensions increased, and stroke volume (SV) fell. Gas exchange, lung compliance, and pH worsened. Subsequent administration of nitroglycerin (5 micrograms.kg-1.min-1) and prostaglandin E1 (0.2 micrograms.kg-1.min-1) caused further decreases in SV and pH. In contrast, hydralazine (mean 0.15 mg/kg) improved myocardial segment shortening, SV, PVR, pulmonary artery flow, and gas exchange. Coronary blood flow increased by 110%. Thus in this canine model of combined pulmonary hypertension and respiratory insufficiency, nitroglycerin and prostaglandin E1 exerted no beneficial cardiopulmonary effects. In contrast, hydralazine improved regional and global RV performance and gas exchange.
No takes yet. Share an insight, caveat, or question.
Hans‐Joachim Priebe (1988) studied Acute pulmonary hypertension and respiratory insufficiency (n=8). Nitroglycerin, prostaglandin E1, and hydralazine was evaluated on Right ventricular function and gas exchange. In a canine model of acute pulmonary hypertension, hydralazine improved RV performance and gas exchange, whereas nitroglycerin and prostaglandin E1 exerted no beneficial cardiopulmonary effects.
Synapse has enriched 10 related papers. Consider them for comparative context: